Clinical Supply

Shanghai skyline

Biotech

EpimAb reels in $120M to propel 3 clinical-stage bispecifics

The funding will push three programs through teh clinic, including a dual checkpoint inhibitor and a T-cell engager that targets CD3 and BCMA.

Amirah Al Idrus Mar 22, 2021 7:00pm

sanofi quebec hq

Sanofi, hit by COVID-19 vaccine setback, kick-starts mRNA trial

Mar 12, 2021 10:44am

blood clot

PhaseBio taps a manufacturing partner for Brilinta-reversing med

Mar 11, 2021 9:50am

merck

Merck must do a new trial for faltering $425M COVID-19 drug

Mar 3, 2021 7:55am

UCB taps Microsoft to accelerate drug discovery, clinical trials

Feb 24, 2021 8:35am

Janssen building

Janssen sends off phase 3 data for a swift WHO pandemic listing

Feb 19, 2021 9:00am